期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
When Does Drug Resistant TB Strike HIV/TB Patients?—A South India Experience
1
作者 Suresh Shastri Sharath Burugina Nagaraja +2 位作者 Jaya Prasad Tripathy Anil Singarajipur Bharat Bhushan Rewari 《World Journal of AIDS》 2017年第1期34-39,共6页
Background: India is a high TB (tuberculosis) burden country. The advent of HIV (Human immunodeficiency virus) and DR-TB (drug resistant TB) has worsened the ongoing TB control efforts. A study was conducted to (a) to... Background: India is a high TB (tuberculosis) burden country. The advent of HIV (Human immunodeficiency virus) and DR-TB (drug resistant TB) has worsened the ongoing TB control efforts. A study was conducted to (a) to determine the duration for developing drug resistant TB after diagnosis of HIV (b) to ascertain the patients status after one year of DR-TB treatment in Karnataka, India. Methods: It is a retrospective cross-sectional study involving review of records and reports at ART (Anti-retroviral treatment) centres and DR-TB centres in Karnataka during the period 2013-2014. Results: The median time from being known as HIV positive to being diagnosed as DR-TB was 1168 days (IQR: 571 - 1955). At the end of 14 months, nearly 39% of patients had died and 49% of patients were on treatment. Conclusion: The National Health programmes should prioritize monitoring of the HIV/TB patients and develop appropriate novel strategies for community involvement. 展开更多
关键词 HIV DR-TB OUTCOMES DURATION
暂未订购
DOST Model’ for DR-TB Patients, New Delhi: Perspectives of Healthcare Providers
2
作者 Vindhya Vatsyayan Theresa Pattery +4 位作者 Khasim Sayyad Jason Williams Arnab Pal Vikas Panibatla Ashwani Khanna 《Journal of Tuberculosis Research》 CAS 2022年第4期187-198,共12页
Introduction: In India, tuberculosis continues to be a major public health problem and there is a growing concern about drug-resistant tuberculosis as most of the patients are from private sector. The National TB Elim... Introduction: In India, tuberculosis continues to be a major public health problem and there is a growing concern about drug-resistant tuberculosis as most of the patients are from private sector. The National TB Elimination Programme (NTEP) in collaboration with TB Alert, India (TBAI) and Clinton Health Association of India (CHAI) had implemented a collaborative project to strengthen the network between the private practitioners and public healthcare facilities in New Delhi during 2019 and 2020. Methods: A study was conducted to understand the enablers and challenges encountered by them during the implementation of the project. This is a qualitative exploration of the “healthcare providers” on a project linking DR-TB patients in private sector with government health facilities. The process of data collection involved face-to-face in-depth interviews of healthcare providers, the Doctors mainly from private and public health facilities, the paramedical workers from general health system and paramedical from the project using an interview guide administered through a trained researcher. Results: The study findings revealed that all healthcare providers were completely aware of the DOST project in the health system, the model led to early diagnosis and initiation of quality treatment. There were no major challenges to the implementation of the project. The healthcare providers wish to have this project implemented for a longer duration. Conclusion: The perspectives of healthcare providers towards the “DOST” project were optimistic and call for re-initiating the project in the area. 展开更多
关键词 DOST Drug-Resistant Tuberculosis Patients INDIA Health Care Providers
在线阅读 下载PDF
应用痰抗酸杆菌涂片批量抽样对镜检中心进行评价
3
作者 N. Selvakumar E. Prabhakaran +9 位作者 B. N. Murthy S. Sivagamasundari S. Vasanthan R. Govindaraju M. Perumal F. Wares L. S. Chauhan T. Santha P. R. Narayanan 张宗德 《结核与肺部疾病杂志》 2005年第4期162-165,共4页
地点:进行痰抗酸菌镜检的指定镜检中心(DMC)和其他镜检中心(AMC),地区结核病中心(DTC)和参比实验室(RL)。目的:使用盲法 AFB 痰涂片对不知晓 AFB 镜检质控的结核病实验室高级督导员(STLS)和经过培训知晓质控的参比实验室(RL)的技术员进... 地点:进行痰抗酸菌镜检的指定镜检中心(DMC)和其他镜检中心(AMC),地区结核病中心(DTC)和参比实验室(RL)。目的:使用盲法 AFB 痰涂片对不知晓 AFB 镜检质控的结核病实验室高级督导员(STLS)和经过培训知晓质控的参比实验室(RL)的技术员进行结果评估,确定批量抽样痰涂片的可行性。方法:镜检中心(MC)的痰涂片送至地区结核病中心(DTC)和参比实验室;经过系统选择每个镜检中心每月送 20 个涂片;DMC 的 1547 张涂片和 AMC 的 726张涂片分别由DTC的STLS和RL的技术员进行检查,由第三者负责分析差别。结果:和 RL 的 1%相比,MC 实验室技术员和 DTC 的STLSs 之间的不符合率为 4.7%。STLSs 与 RL 实验室技术员各有 70 次和 2 次错误。结论:AFB 涂片的批量抽样在现场情况下是可行的。受过 AFB 涂片镜检质控培训的 RL 技术员对 MC 的评价比没有受过此训练的 STLSs 更有效。 展开更多
关键词 肺结核 批量抽样 痰涂片 AFB 质控 涂片镜检 痰抗酸杆菌 抽样 批量 实验室
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部